{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:01:35Z","timestamp":1793142095781,"version":"4.5.0"},"reference-count":33,"publisher":"Cambridge University Press (CUP)","issue":"9","license":[{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec id=\"S0033291717000162_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Several studies have examined whether use of substances can cause schizophrenia. However, due to methodological limitations in the existing literature (e.g. selection bias and lack of adjustment of co-abuse) uncertainties still remain. We aimed to investigate whether substance abuse increases the risk of developing schizophrenia, addressing some of these limitations.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000162_sec_a2\" sec-type=\"methods\"><jats:title>Method<\/jats:title><jats:p>The longitudinal, nationwide Danish registers were linked to establish a cohort of 3 133 968 individuals (105 178 673 person-years at risk), identifying 204 505 individuals diagnosed with substance abuse and 21 305 diagnosed with schizophrenia. Information regarding substance abuse was extracted from several registers and did not include psychotic symptoms caused by substance abuse in the definition. This resulted in a large, generalizable sample of exposed individuals. The data was analysed using Cox regression analyses, and adjusted for calendar year, gender, urbanicity, co-abuse, other psychiatric diagnosis, parental substance abuse, psychiatric history, immigration and socioeconomic status.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000162_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>A diagnosis of substance abuse increased the overall risk of developing schizophrenia [hazard ratio (HR) 6.04, 95% confidence interval (CI) 5.84\u20136.26]. Cannabis (HR 5.20, 95% CI 4.86\u20135.57) and alcohol (HR 3.38, 95% CI 3.24\u20133.53) presented the strongest associations. Abuse of hallucinogens (HR 1.86, 95% CI 1.43\u20132.41), sedatives (HR 1.68, 95% CI 1.49\u20131.90), and other substances (HR 2.85, 95% CI 2.58\u20133.15) also increased the risk significantly. The risk was found to be significant even 10\u201315 years subsequent to a diagnosis of substance abuse.<\/jats:p><\/jats:sec><jats:sec id=\"S0033291717000162_sec_a4\" sec-type=\"conclusion\"><jats:title>Conclusion<\/jats:title><jats:p>Our results illustrate robust associations between almost any type of substance abuse and an increased risk of developing schizophrenia later in life.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0033291717000162","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T11:14:31Z","timestamp":1486466071000},"page":"1668-1677","source":"Crossref","is-referenced-by-count":81,"title":["Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study"],"prefix":"10.1017","volume":"47","author":[{"given":"S. M.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. G.","family":"Toftdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hjorth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"S0033291717000162_ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.16"},{"key":"S0033291717000162_ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.17"},{"key":"S0033291717000162_ref23","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2015.1004581"},{"key":"S0033291717000162_ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-015-1104-4"},{"key":"S0033291717000162_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/nature09563"},{"key":"S0033291717000162_ref22","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r07222"},{"key":"S0033291717000162_ref32","doi-asserted-by":"publisher","DOI":"10.1002\/9780470976739"},{"key":"S0033291717000162_ref9","unstructured":"EMCDDA (2011). Annual report 2011. The state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction, p. 112."},{"key":"S0033291717000162_ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.169"},{"key":"S0033291717000162_ref16","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp031"},{"key":"S0033291717000162_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00152-2"},{"key":"S0033291717000162_ref26","first-page":"441","article-title":"The Danish Civil Registration System. A cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Danish Medical Bulletin"},{"key":"S0033291717000162_ref8","unstructured":"EMCDDA (2015). European Drug Report 2015. Trends and developments. European Monitoring Centre for Drugs and Drug Addiction."},{"key":"S0033291717000162_ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810395825"},{"key":"S0033291717000162_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00491982"},{"key":"S0033291717000162_ref4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10070937"},{"key":"S0033291717000162_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60995-8"},{"key":"S0033291717000162_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16200-4"},{"key":"S0033291717000162_ref33","first-page":"1","article-title":"The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good","volume":"60","author":"Uggerby","year":"2013","journal-title":"Danish Medical Journal"},{"key":"S0033291717000162_ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394717"},{"key":"S0033291717000162_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9457-4"},{"key":"S0033291717000162_ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-011-9273-7"},{"key":"S0033291717000162_ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d738"},{"key":"S0033291717000162_ref29","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu132"},{"key":"S0033291717000162_ref2","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Danish Medical Bulletin"},{"key":"S0033291717000162_ref7","unstructured":"Danish Health Data Authority (2015 b). The National Alcohol Treatment Register. (http:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygedomme-laegemidler-og-behandlinger\/alkoholbehandlingsregisteret). Accessed 25 January 2017."},{"key":"S0033291717000162_ref28","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.51"},{"key":"S0033291717000162_ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.3.196"},{"key":"S0033291717000162_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61162-3"},{"key":"S0033291717000162_ref19","first-page":"T126","article-title":"Tobacco smoking and risk of first episode psychosis: a case-control study in Sao Paulo, Brazil","author":"Menezes","year":"2016","journal-title":"Schizophrenia"},{"key":"S0033291717000162_ref30","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1176\/ajp.148.12.1708","article-title":"Cocaine-induced paranoia and psychosis proneness","volume":"148","author":"Satel","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"S0033291717000162_ref1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"S0033291717000162_ref6","unstructured":"Danish Health Data Authority (2015 a). The National Substance Abuse Register. (http:\/\/sundhedsdatastyrelsen.dk\/da\/registre-og-services\/om-de-nationale-sundhedsregistre\/sygedomme-laegemidler-og-behandlinger\/stofmisbrugere-i-behandling). Accessed 25 January 2017."}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291717000162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T02:42:20Z","timestamp":1749955340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291717000162\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0033291717000162"],"URL":"https:\/\/doi.org\/10.1017\/s0033291717000162","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}